Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Accumulated Depreciation & Amortization: 2013-2020

  • Larimar Therapeutics' Accumulated Depreciation & Amortization was N/A to $284,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $179,000 for FY2019, which is 67.45% down from last year.
  • Latest data reveals that Larimar Therapeutics reported Accumulated Depreciation & Amortization of $284,000 as of Q3 2020, which was up 21.37% from $234,000 recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Accumulated Depreciation & Amortization registered a high of $550,000 during Q4 2018, and its lowest value of $179,000 during Q4 2019.
  • Over the past 3 years, Larimar Therapeutics' median Accumulated Depreciation & Amortization value was $259,000 (recorded in 2020), while the average stood at $311,750.
  • As far as peak fluctuations go, Larimar Therapeutics' Accumulated Depreciation & Amortization soared by 166.67% in 2016, and later crashed by 67.45% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $320,000 in 2016, then skyrocketed by 58.75% to $508,000 in 2017, then grew by 8.27% to $550,000 in 2018, then tumbled by 67.45% to $179,000 in 2019, then reached $284,000 in 2020.
  • Its last three reported values are $284,000 in Q3 2020, $234,000 for Q2 2020, and $179,000 during Q4 2019.